Fleming, K.E.; Hupel, A.; Mithoowani, H.; Lulic-Kuryllo, T.; Valdes, M.
Biomarker Turnaround Times and Impact on Treatment Decisions in Patients with Advanced Non-Small Cell Lung Carcinoma at a Large Canadian Community Hospital with an Affiliated Regional Cancer Centre. Curr. Oncol. 2024, 31, 1515-1528.
https://doi.org/10.3390/curroncol31030115
AMA Style
Fleming KE, Hupel A, Mithoowani H, Lulic-Kuryllo T, Valdes M.
Biomarker Turnaround Times and Impact on Treatment Decisions in Patients with Advanced Non-Small Cell Lung Carcinoma at a Large Canadian Community Hospital with an Affiliated Regional Cancer Centre. Current Oncology. 2024; 31(3):1515-1528.
https://doi.org/10.3390/curroncol31030115
Chicago/Turabian Style
Fleming, Katelyn E., Ava Hupel, Hamid Mithoowani, Tea Lulic-Kuryllo, and Mario Valdes.
2024. "Biomarker Turnaround Times and Impact on Treatment Decisions in Patients with Advanced Non-Small Cell Lung Carcinoma at a Large Canadian Community Hospital with an Affiliated Regional Cancer Centre" Current Oncology 31, no. 3: 1515-1528.
https://doi.org/10.3390/curroncol31030115
APA Style
Fleming, K. E., Hupel, A., Mithoowani, H., Lulic-Kuryllo, T., & Valdes, M.
(2024). Biomarker Turnaround Times and Impact on Treatment Decisions in Patients with Advanced Non-Small Cell Lung Carcinoma at a Large Canadian Community Hospital with an Affiliated Regional Cancer Centre. Current Oncology, 31(3), 1515-1528.
https://doi.org/10.3390/curroncol31030115
